Stage III Ovarian Epithelial Cancer Completed Phase 3 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00041080Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTreatment